Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

J&J Pops on Decision to Split Consumer Health Business

Stock Markets Nov 12, 2021 13:42
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.
 
LLY
-0.56%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
PFE
+0.87%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
JNJ
-0.10%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GE
+2.73%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GSK
+2.79%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6502
+1.02%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Dhirendra Tripathi

Investing.com – Johnson & Johnson (NYSE:JNJ) stock jumped more than 5% in Friday’s trading as the company revealed its plan to split its consumer health business into a separate listed entity.

The separation is expected to take 18 to 24 months to complete, J&J said in a release.

The consumer health segment that houses brands such as Neutrogena, Band-Aid, Listerine and Tylenol, is expected to generate revenue of approximately $15 billion in the ongoing financial year. That compares with the roughly $77 billion generated by the pharmaceutical and medical device unit, which also sells the Covid-19 vaccine. 

J&J’s Covid vaccine is one of the only three allowed to be sold in the U.S. The other two belong to Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA), respectively.

J&J is the third big company in less than a week to have announced separation of their businesses, General Electric (NYSE:GE) and Toshiba (T:6502) before it. It also echoes a similar process also underway at the U.K.'s GlaxoSmithKline (NYSE:GSK).  Conglomerates have tended to traded at discounts to specialist companies in the past, and J&J's current price-earnings multiple of 24 compares poorly to - for example - Eli Lilly (NYSE:LLY) stock, which trades at over 40 times earnings.

As per a reorganization announced on Friday, Alex Gorsky will serve as Executive Chairman of J&J and pass the Chief Executive Officer's role to Joaquin Duato.

According to The Wall Street Journal, J&J has planned the restructuring so as to be tax-free. It is likely J&J would spin out its consumer unit and hold a stock offering, but no decision has been made, Gorsky told the Journal.

 

 

 

 

 

J&J Pops on Decision to Split Consumer Health Business
 

Related Articles

European Stocks Higher; Eurozone PPI Data Due
European Stocks Higher; Eurozone PPI Data Due By Investing.com - Oct 04, 2022

By Peter Nurse  Investing.com - European stock markets climbed higher Tuesday, building on the previous session’s positive start to the new quarter. By 03:45 ET (07:45 GMT), the...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email